© Natali Kadosh, ICL Group PR ICL Israel Chemicals earnings missed by $0.01, revenue fell short of estimates
Investing.com – ICL Israel Chemicals (NYSE: ICL) reported fourth quarter EPS of $0.280, $0.01 worse than the analyst estimate of $0.295. Revenue for the quarter came in at $2.09B versus the consensus estimate of $2.55B.
ICL Israel Chemicals’s stock price closed at $7.670. It is down -6.120% in the last 3 months and down -24.800% in the last 12 months.
ICL Israel Chemicals saw 0 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See ICL Israel Chemicals’s stock price’s past reactions to earnings here.
According to InvestingPro, ICL Israel Chemicals’s Financial Health score is “great performance“.
Check out ICL Israel Chemicals’s , and ICL Israel Chemicals’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Be the first to comment